YWCA Metro Vancouver has announced 78 nominees, including one Delta nominee, for its 40th annual Women of Distinction Awards presented by Scotiabank.
This year’s nominee from Delta is Dr. Nina Weisser, Director of Multispecific Antibody Therapeutics at Vancouver-based Zymeworks Inc.
Weisser is nominated under the Research, the Sciences and Technology category.
Weisser leads Zymeworks’ Multispecific Antibody Therapeutic Preclinical Programs group in the development of new antibody-based compounds and therapeutic platforms that have the potential to harness the body’s immune system to treat various cancers.
At Zymeworks, she has led the development of zanidatamab, a therapeutic currently in global clinical trials that has demonstrated positive outcomes, impacting patients around the world. The development of zanidatamab, and Weisser’s dedication, scientific excellence and resilience in unlocking its beneficial properties, has been a key cornerstone for Zymeworks’ success as a Vancouver-based biotech company.
The YWCA Women of Distinction Awards honour individuals and organizations whose outstanding activities and achievements contribute to the well-being and future of our community. This year is the 40th year of the Women of Distinction Awards. Since 1984, YWCA Metro Vancouver has paid tribute to more than 352 award recipients and 2,100 nominees.
In addition to the 12 nomination categories, the individual nominees are eligible for the Connecting the Community Award. Nominees will select a YWCA advocacy area in which they are interested and use social media channels such as Twitter and LinkedIn to promote votes.
From March 8 to April 12, the public can cast their votes online and the nominee with the most votes will receive the Connecting the Community Award. Scotiabank will donate $10,000 to the YWCA program area of the winner’s choice.
Award recipients will be announced at the Women of Distinction Awards Gala at the Westin Bayshore in Vancouver on May 9.
See more on the awards at: ywcavan.org/wod.
